"Centro Médico de atención integral ambulatoria de pacientes Oncológicos"

During the past decade, Centro Medico San Roque conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Medico San Roque" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Helsinn Healthcare SA" with 2 trials sponsored and "Merck Sharp & Dohme LLC" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Medico San Roque" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Centro Medico San Roque" are "Breast Cancer" (3 trials), "Metastatic Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Chemotherapy-Induced Nausea and Vomiting" (2 trials) and "Neoplasm Metastasis" (2 trials). Many other conditions were trialed in "Centro Medico San Roque" in a lesser frequency.

Most popular intervention types in "Centro Medico San Roque" are "Drug" (22 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Abemaciclib" (4 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Medico San Roque" are 18 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Medico San Roque". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centro Medico San Roque, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Medico San Roque, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".